Hình ảnh cấu trúc của các tương tác kinase RAF

Rapp, 1983, Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus, Proc. Natl Acad. Sci. U.S.A., 80, 4218, 10.1073/pnas.80.14.4218

Bonner, 1985, Structure and biological activity of human homologs of the raf/mil oncogene, Mol. Cell. Biol., 5, 1400, 10.1128/MCB.5.6.1400

Huleihel, 1986, Characterization of murine A-raf, a new oncogene related to the v-raf oncogene, Mol. Cell. Biol., 6, 2655, 10.1128/MCB.6.7.2655

Ikawa, 1988, B-raf, a new member of the raf family, is activated by DNA rearrangement, Mol. Cell. Biol., 8, 2651, 10.1128/MCB.8.6.2651

Han, 1993, C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation, Nature, 363, 133, 10.1038/363133a0

Mark, 1987, Drosophila melanogaster homologs of the raf oncogene, Mol. Cell. Biol., 7, 2134, 10.1128/MCB.7.6.2134

Hsu, 2002, Caenorhabditis elegans lin-45 raf is essential for larval viability, fertility and the induction of vulval cell fates, Genetics, 160, 481, 10.1093/genetics/160.2.481

Morrison, 1990, The Raf-1 kinase as a transducer of mitogenic signals, Cancer Cells, 2, 377

Avruch, 2001, Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade, Recent Prog. Horm. Res., 56, 127, 10.1210/rp.56.1.127

Wellbrock, 2004, The RAF proteins take centre stage, Nat. Rev. Mol. Cell Biol., 5, 875, 10.1038/nrm1498

Leicht, 2007, Raf kinases: function, regulation and role in human cancer, Biochim. Biophys. Acta, 1773, 1196, 10.1016/j.bbamcr.2007.05.001

Osborne, 2012, Signal control through Raf: in sickness and in health, Cell Res., 22, 14, 10.1038/cr.2011.193

Desideri, 2015, Alike but different: RAF paralogs and their signaling outputs, Cell, 161, 967, 10.1016/j.cell.2015.04.045

Niault, 2010, Targets of Raf in tumorigenesis, Carcinogenesis, 31, 1165, 10.1093/carcin/bgp337

Sanges, 2012, Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells, Cell Death Dis., 3, e276, 10.1038/cddis.2012.16

An, 2015, A-Raf: a new star of the family of raf kinases, Crit. Rev. Biochem. Mol. Biol., 50, 520, 10.3109/10409238.2015.1102858

Downward, 2003, Targeting RAS signalling pathways in cancer therapy, Nat. Rev. Cancer, 3, 11, 10.1038/nrc969

Maurer, 2011, Raf kinases in cancer-roles and therapeutic opportunities, Oncogene, 30, 3477, 10.1038/onc.2011.160

Roring, 2012, Aberrant B-Raf signaling in human cancer — 10 years from bench to bedside, Crit. Rev. Oncog., 17, 97, 10.1615/CritRevOncog.v17.i1.70

Allanson, 2011, Cardio-facio-cutaneous syndrome: does genotype predict phenotype?, Am. J. Med. Genet. C Semin. Med. Genet., 157, 129, 10.1002/ajmg.c.30295

Tartaglia, 2011, Noonan syndrome and clinically related disorders, Best Pract. Res. Clin. Endocrinol. Metab., 25, 161, 10.1016/j.beem.2010.09.002

Vandamme, 2014, Regulation of the MAPK pathway by raf kinase inhibitory protein, Crit. Rev. Oncogenesis, 19, 405, 10.1615/CritRevOncog.2014011922

Morrison, 1997, The complexity of Raf-1 regulation, Curr. Opin. Cell Biol., 9, 174, 10.1016/S0955-0674(97)80060-9

Dhillon, 2007, MAP kinase signalling pathways in cancer, Oncogene, 26, 3279, 10.1038/sj.onc.1210421

Roberts, 2007, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, 26, 3291, 10.1038/sj.onc.1210422

Karnoub, 2008, Ras oncogenes: split personalities, Nat. Rev. Mol. Cell Biol., 9, 517, 10.1038/nrm2438

Rauch, 2016, MAPK kinase signalling dynamics regulate cell fate decisions and drug resistance, Curr. Opin. Struct. Biol., 41, 151, 10.1016/j.sbi.2016.07.019

Zhang, 1993, Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1, Nature, 364, 308, 10.1038/364308a0

Vojtek, 1993, Mammalian Ras interacts directly with the serine/threonine kinase Raf, Cell, 74, 205, 10.1016/0092-8674(93)90307-C

Moodie, 1993, Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase, Science, 260, 1658, 10.1126/science.8503013

Warne, 1993, Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro, Nature, 364, 352, 10.1038/364352a0

Van Aelst, 1993, Complex formation between RAS and RAF and other protein kinases, Proc. Natl Acad. Sci. U.S.A., 90, 6213, 10.1073/pnas.90.13.6213

Kyriakis, 1992, Raf-1 activates MAP kinase-kinase, Nature, 358, 417, 10.1038/358417a0

Matallanas, 2011, Raf family kinases: old dogs have learned new tricks, Genes Cancer, 2, 232, 10.1177/1947601911407323

Baljuls, 2013, It takes two to tango — signalling by dimeric Raf kinases, Mol. Biosyst., 9, 551, 10.1039/C2MB25393C

Marais, 1997, Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases, J. Biol. Chem., 272, 4378, 10.1074/jbc.272.7.4378

Leicht, 2013, MEK-1 activates C-Raf through a Ras-independent mechanism, Biochim. Biophys. Acta, 1833, 976, 10.1016/j.bbamcr.2013.01.015

Rushworth, 2006, Regulation and role of Raf-1/B-Raf heterodimerization, Mol. Cell. Biol., 26, 2262, 10.1128/MCB.26.6.2262-2272.2006

Rodriguez-Viciana, 2006, A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity, Mol. Cell, 22, 217, 10.1016/j.molcel.2006.03.027

Freeman, 2013, The importance of Raf dimerization in cell signaling, Small GTPases, 4, 180, 10.4161/sgtp.26117

Lavoie, 2014, Dimerization-induced allostery in protein kinase regulation, Trends Biochem. Sci., 39, 475, 10.1016/j.tibs.2014.08.004

Lavoie, 2015, Regulation of RAF protein kinases in ERK signalling, Nat. Rev. Mol. Cell Biol., 16, 281, 10.1038/nrm3979

Gutierrez-Erlandsson, 2013, R-RAS2 overexpression in tumors of the human central nervous system, Mol. Cancer, 12, 127, 10.1186/1476-4598-12-127

Herrmann, 2003, Ras-effector interactions: after one decade, Curr. Opin. Struct. Biol., 13, 122, 10.1016/S0959-440X(02)00007-6

Castellano, 2010, Role of RAS in the regulation of PI 3-kinase, Curr. Top. Microbiol. Immunol., 346, 143

Rajalingam, 2007, Ras oncogenes and their downstream targets, Biochim. Biophys. Acta, 1773, 1177, 10.1016/j.bbamcr.2007.01.012

Nakhaei-Rad, 2018, Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms, Crit. Rev. Biochem. Mol. Biol., 53, 130, 10.1080/10409238.2018.1431605

Repasky, 2004, Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?, Trends Cell Biol., 14, 639, 10.1016/j.tcb.2004.09.014

Wohlgemuth, 2005, Recognizing and defining true Ras binding domains I: biochemical analysis, J. Mol. Biol., 348, 741, 10.1016/j.jmb.2005.02.048

Nakhaeizadeh, 2016, The RAS-effector interface: isoform-specific differences in the effector binding regions, PLoS ONE, 11, e0167145, 10.1371/journal.pone.0167145

Patel, 2013, Ras GTPases’ interaction with effector domains: breaking the families’ barrier, Commun. Integr. Biol., 6, e24298, 10.4161/cib.24298

Herrmann, 1996, Ras and its effectors, Prog. Biophys. Mol. Biol., 66, 1, 10.1016/S0079-6107(96)00015-6

Mott, 2015, Structures of Ras superfamily effector complexes: what have we learnt in two decades?, Crit. Rev. Biochem. Mol. Biol., 50, 85, 10.3109/10409238.2014.999191

Mazhab-Jafari, 2015, Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site, Proc. Natl Acad. Sci. U.S.A., 112, 6625, 10.1073/pnas.1419895112

Vetter, 2001, The guanine nucleotide-binding switch in three dimensions, Science, 294, 1299, 10.1126/science.1062023

Drugan, 1996, Ras interaction with two distinct binding domains in Raf-1 5 be required for Ras transformation, J. Biol. Chem., 271, 233, 10.1074/jbc.271.1.233

Thapar, 2004, NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation, J. Mol. Biol., 343, 1391, 10.1016/j.jmb.2004.08.106

Athuluri-Divakar, 2016, A small molecule RAS-mimetic disrupts RAS association with effector proteins to block signaling, Cell, 165, 643, 10.1016/j.cell.2016.03.045

Nassar, 1995, The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue, Nature, 375, 554, 10.1038/375554a0

Huang, 1998, Structural basis for the interaction of Ras with RalGDS, Nat. Struct. Biol., 5, 422, 10.1038/nsb0698-422

Stieglitz, 2008, Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II, EMBO J., 27, 1995, 10.1038/emboj.2008.125

Pacold, 2000, Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma, Cell, 103, 931, 10.1016/S0092-8674(00)00196-3

Bunney, 2006, Structural and mechanistic insights into ras association domains of phospholipase C epsilon, Mol. Cell, 21, 495, 10.1016/j.molcel.2006.01.008

Marshall, 1993, The effector interactions of p21ras, Trends Biochem. Sci., 18, 250, 10.1016/0968-0004(93)90175-M

Wittinghofer, 1995, Ras-effector interactions, the problem of specificity, FEBS Lett., 369, 52, 10.1016/0014-5793(95)00667-X

Marshall, 1996, Ras effectors, Curr. Opin. Cell Biol., 8, 197, 10.1016/S0955-0674(96)80066-4

Wittinghofer, 1996, How Ras-related proteins talk to their effectors, Trends Biochem. Sci., 21, 488, 10.1016/S0968-0004(96)10064-5

Wittinghofer, 1998, Signal transduction via Ras, Biol. Chem., 379, 933

Corbett, 2001, The many faces of Ras: recognition of small GTP-binding proteins, Trends Biochem. Sci., 26, 710, 10.1016/S0968-0004(01)01974-0

Spaargaren, 1994, The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner, Biochem. J., 300, 303, 10.1042/bj3000303

Koide, 1993, GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells, Proc. Natl Acad. Sci. U.S.A., 90, 8683, 10.1073/pnas.90.18.8683

Barnard, 1995, Identification of the sites of interaction between c-Raf-1 and Ras-GTP, Oncogene, 10, 1283

Herrmann, 1995, Quantitative analysis of the complex between p21 and the ras-binding domain of the human raf-1 protein kinase, J. Biol. Chem., 270, 2901, 10.1074/jbc.270.7.2901

Nassar, 1996, Ras/Rap effector specificity determined by charge reversal, Nat. Struct. Biol., 3, 723, 10.1038/nsb0896-723

Lavoie, 2018, MEK drives BRAF activation through allosteric control of KSR proteins, Nature, 554, 549, 10.1038/nature25478

Filchtinski, 2010, What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf, J Mol Biol., 399, 422, 10.1016/j.jmb.2010.03.046

Fetics, 2015, Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD, Structure, 23, 505, 10.1016/j.str.2014.12.017

Mott, 1996, The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site, Proc. Natl Acad. Sci., 93, 8312, 10.1073/pnas.93.16.8312

Molzan, 2010, Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling, Mol. Cell. Biol., 30, 4698, 10.1128/MCB.01636-09

Molzan, 2012, Synergistic binding of the phosphorylated S233-and S259-binding sites of C-RAF to one 14-3-3ζ dimer, J. Mol. Biol., 423, 486, 10.1016/j.jmb.2012.08.009

Molzan, 2013, Stabilization of physical RAF/14-3-3 interaction by cotylenin A as treatment strategy for RAS mutant cancers, ACS Chem. Biol., 8, 1869, 10.1021/cb4003464

Wan, 2004, Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF, Cell, 116, 855, 10.1016/S0092-8674(04)00215-6

Haling, 2014, Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling, Cancer Cell, 26, 402, 10.1016/j.ccr.2014.07.007

Sprang, 1995, How Ras works: structure of a Rap-Raf complex, Structure, 3, 641, 10.1016/S0969-2126(01)00198-8

Erijman, 2016, RAS/effector interactions from structural and biophysical perspective, Mini-Rev. Med. Chem., 16, 370, 10.2174/1389557515666151001141838

Block, 1996, Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo, Nat. Struct. Biol., 3, 244, 10.1038/nsb0396-244

Fridman, 2000, Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras, J. Biol. Chem., 275, 30363, 10.1074/jbc.M003193200

Zehir, 2017, Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients, Nat. Med., 23, 703, 10.1038/nm.4333

Zeng, 1999, Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding, Protein Sci., 8, 50, 10.1110/ps.8.1.50

Weber, 2000, Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes, Oncogene, 19, 169, 10.1038/sj.onc.1203261

Lim, 2015, Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels, Oncotarget, 6, 22179, 10.18632/oncotarget.4246

Lefebvre, 2016, Mutational profile of metastatic breast cancers: a retrospective analysis, PLoS Med., 13, e1002201, 10.1371/journal.pmed.1002201

Terada, 1999, Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins, J. Mol. Biol., 286, 219, 10.1006/jmbi.1998.2472

Kiel, 2009, Improved binding of raf to Ras.GDP is correlated with biological activity, J. Biol. Chem., 284, 31893, 10.1074/jbc.M109.031153

Chavan, 2015, Plasma membrane regulates Ras signaling networks, Cell Logist., 5, e1136374, 10.1080/21592799.2015.1136374

Bondeva, 2002, Structural determinants of Ras-Raf interaction analyzed in live cells, Mol. Biol. Cell., 13, 2323, 10.1091/mbc.e02-01-0019

Nekhoroshkova, 2009, A-RAF kinase functions in ARF6 regulated endocytic membrane traffic, PLoS ONE, 4, e4647, 10.1371/journal.pone.0004647

Giannakis, 2016, Genomic correlates of immune-cell infiltrates in colorectal carcinoma, Cell Rep., 15, 857, 10.1016/j.celrep.2016.03.075

George, 2015, Comprehensive genomic profiles of small cell lung cancer, Nature, 524, 47, 10.1038/nature14664

Mouradov, 2014, Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer, Cancer Res., 74, 3238, 10.1158/0008-5472.CAN-14-0013

Fischer, 2007, B- and C-RAF display essential differences in their binding to Ras: the isotype-specific N terminus of B-RAF facilitates Ras binding, J. Biol. Chem., 282, 26503, 10.1074/jbc.M607458200

Chuang, 1994, Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues, Mol. Cell. Biol., 14, 5318, 10.1128/MCB.14.8.5318

Li, 2018, A ‘Tug of War’ maintains a dynamic protein-membrane complex: molecular dynamics simulations of C-Raf RBD-CRD bound to K-Ras4B at an anionic membrane, ACS Cent. Sci., 4, 298, 10.1021/acscentsci.7b00593

Abaan, 2013, The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology, Cancer Res., 73, 4372, 10.1158/0008-5472.CAN-12-3342

Li, 2018, Raf-1 cysteine-Rich domain increases the affinity of K-Ras/Raf at the membrane, promoting MAPK signaling, Structure, 26, 513, 10.1016/j.str.2018.01.011

Brtva, 1995, Two distinct Raf domains mediate interaction with Ras, J. Biol. Chem., 270, 9809, 10.1074/jbc.270.17.9809

Hu, 1995, Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras, J. Biol. Chem., 270, 30274, 10.1074/jbc.270.51.30274

Hu, 1997, Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1, J. Biol. Chem., 272, 11702, 10.1074/jbc.272.18.11702

Roy, 1997, Activity of plasma membrane-recruited Raf-1 is regulated by Ras via the Raf zinc finger, J. Biol. Chem., 272, 20139, 10.1074/jbc.272.32.20139

Luo, 1997, An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ, Mol. Cell. Biol., 17, 46, 10.1128/MCB.17.1.46

Daub, 1998, The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation, Mol. Cell. Biol., 18, 6698, 10.1128/MCB.18.11.6698

Okada, 1999, The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases, Mol. Cell. Biol., 19, 6057, 10.1128/MCB.19.9.6057

Williams, 2000, Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions, J. Biol. Chem., 275, 22172, 10.1074/jbc.M000397200

Chan, 2002, Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity, Mol. Carcinog., 33, 189, 10.1002/mc.10031

Hibino, 2011, Activation kinetics of RAF protein in the ternary complex of RAF, RAS-GTP, and kinase on the plasma membrane of living cells: single-molecule imaging analysis, J. Biol. Chem., 286, 36460, 10.1074/jbc.M111.262675

Ke, 2017, Structural basis for intramolecular interaction of post-translationally modified H-Ras*GTP prepared by protein ligation, FEBS Lett., 591, 2470, 10.1002/1873-3468.12759

Ghosh, 1994, The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras, J. Biol. Chem., 269, 10000, 10.1016/S0021-9258(17)36981-8

Hekman, 2002, Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts, J. Biol. Chem., 277, 24090, 10.1074/jbc.M200576200

Ghosh, 1996, Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells, J. Biol. Chem., 271, 8472, 10.1074/jbc.271.14.8472

Zang, 2001, Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. Insights into mechanisms of Raf-1 activation, J. Biol. Chem., 276, 25157, 10.1074/jbc.M100152200

Improta-Brears, 1999, Mutational analysis of Raf-1 cysteine rich domain: requirement for a cluster of basic aminoacids for interaction with phosphatidylserine, Mol. Cell. Biochem., 198, 171, 10.1023/A:1006981411691

Sarkozy, 2009, Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum, Hum. Mutat., 30, 695, 10.1002/humu.20955

Abankwa, 2007, Ras nanoclusters: molecular structure and assembly, Semin. Cell Dev. Biol., 18, 599, 10.1016/j.semcdb.2007.08.003

Abankwa, 2010, Ras membrane orientation and nanodomain localization generate isoform diversity, Proc. Natl Acad. Sci. U.S.A., 107, 1130, 10.1073/pnas.0903907107

Cirstea, 2010, A restricted spectrum of NRAS mutations causes Noonan syndrome, Nat. Genet., 42, 27, 10.1038/ng.497

Zhou, 2018, Deciphering lipid codes: K-Ras as a paradigm, Traffic, 19, 157, 10.1111/tra.12541

Kapoor, 2012, Revealing conformational substates of lipidated N-Ras protein by pressure modulation, Proc. Natl Acad. Sci. U.S.A., 109, 460, 10.1073/pnas.1110553109

Vogel, 2014, Interaction of the human N-Ras protein with lipid raft model membranes of varying degrees of complexity, Biol. Chem., 395, 779, 10.1515/hsz-2013-0294

Sperlich, 2016, Regulation of K-Ras4B membrane binding by calmodulin, Biophys. J., 111, 113, 10.1016/j.bpj.2016.05.042

Erwin, 2017, Influence of isoform-specific Ras lipidation motifs on protein partitioning and dynamics in model membrane systems of various complexity, Biol. Chem., 398, 290, 10.1515/hsz-2016-0289

Dumaz, 2003, Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras, J. Biol. Chem., 278, 29819, 10.1074/jbc.C300182200

Sendoh, 2000, Role of Raf-1 conserved region 2 in regulation of Ras-dependent Raf-1 activation, Biochem. Biophys. Res. Commun., 271, 596, 10.1006/bbrc.2000.2674

Dhillon, 2002, Regulation of Raf-1 activation and signalling by dephosphorylation, EMBO J., 21, 64, 10.1093/emboj/21.1.64

Dhillon, 2002, Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259, Mol. Cell. Biol., 22, 3237, 10.1128/MCB.22.10.3237-3246.2002

Zimmermann, 1999, Phosphorylation and regulation of Raf by Akt (protein kinase B), Science, 286, 1741, 10.1126/science.286.5445.1741

Rommel, 1999, Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt, Science, 286, 1738, 10.1126/science.286.5445.1738

Pandit, 2007, Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nat. Genet., 39, 1007, 10.1038/ng2073

Razzaque, 2007, Germline gain-of-function mutations in RAF1 cause Noonan syndrome, Nat. Genet., 39, 1013, 10.1038/ng2078

Kobayashi, 2010, Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation, Hum. Mutat., 31, 284, 10.1002/humu.21187

Hodis, 2012, A landscape of driver mutations in melanoma, Cell, 150, 251, 10.1016/j.cell.2012.06.024

Martin, 2014, The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies, Oncotarget, 5, 8906, 10.18632/oncotarget.2417

Shi, 2016, Somatic genomics and clinical features of lung adenocarcinoma: a retrospective study, PLoS Med., 13, e1002162, 10.1371/journal.pmed.1002162

Imielinski, 2014, Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma, J. Clin. Invest., 124, 1582, 10.1172/JCI72763

Stevers, 2018, Modulators of 14-3-3 protein-protein interactions, J. Med. Chem., 61, 3755, 10.1021/acs.jmedchem.7b00574

Yaffe, 1997, The structural basis for 14-3-3:phosphopeptide binding specificity, Cell, 91, 961, 10.1016/S0092-8674(00)80487-0

Shen, 2003, Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding, Mol. Biol. Cell, 14, 4721, 10.1091/mbc.e02-12-0821

Tzivion, 2002, 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation, J. Biol. Chem., 277, 3061, 10.1074/jbc.R100059200

Muslin, 1996, Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine, Cell, 84, 889, 10.1016/S0092-8674(00)81067-3

Morrison, 1993, Identification of the major phosphorylation sites of the Raf-1 kinase, J. Biol. Chem., 268, 17309, 10.1016/S0021-9258(19)85336-X

Roskoski, 2010, RAF protein-serine/threonine kinases: structure and regulation, Biochem. Biophys. Res. Commun., 399, 313, 10.1016/j.bbrc.2010.07.092

Alessi, 1994, Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1, EMBO J., 13, 1610, 10.1002/j.1460-2075.1994.tb06424.x

Roskoski, 2012, MEK1/2 dual-specificity protein kinases: structure and regulation, Biochem. Biophys. Res. Commun., 417, 5, 10.1016/j.bbrc.2011.11.145

Hatzivassiliou, 2010, RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth, Nature, 464, 431, 10.1038/nature08833

Yao, 2015, BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition, Cancer Cell, 28, 370, 10.1016/j.ccell.2015.08.001

Yao, 2017, Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS, Nature, 548, 234, 10.1038/nature23291

Karoulia, 2016, An integrated model of RAF inhibitor action predicts inhibitor activity against oncogenic BRAF signaling, Cancer Cell, 30, 485, 10.1016/j.ccell.2016.06.024

Brown, 2009, Protein scaffolds in MAP kinase signalling, Cell. Signal., 21, 462, 10.1016/j.cellsig.2008.11.013

Morrison, 2003, Regulation of MAP kinase signaling modules by scaffold proteins in mammals, Ann. Rev. Cell Dev. Biol., 19, 91, 10.1146/annurev.cellbio.19.111401.091942

Liang, 2016, Scaffold proteins regulating extracellular regulated kinase function in cardiac hypertrophy and disease, Front. Pharmacol., 7, 37, 10.3389/fphar.2016.00037

Shaul, 2007, The MEK/ERK cascade: from signaling specificity to diverse functions, Biochim. Biophys. Acta, 1773, 1213, 10.1016/j.bbamcr.2006.10.005

Wortzel, 2011, The ERK cascade: distinct functions within various subcellular organelles, Genes Cancer, 2, 195, 10.1177/1947601911407328

Kornfeld, 1995, The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans, Cell, 83, 903, 10.1016/0092-8674(95)90206-6

Sundaram, 1995, The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction, Cell, 83, 889, 10.1016/0092-8674(95)90205-8

Therrien, 1995, KSR, a novel protein kinase required for RAS signal transduction, Cell, 83, 879, 10.1016/0092-8674(95)90204-X

Vomastek, 2004, Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists, Proc. Natl Acad. Sci. U.S.A., 101, 6981, 10.1073/pnas.0305894101

Schaeffer, 1998, MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade, Science, 281, 1668, 10.1126/science.281.5383.1668

Ishibe, 2003, Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis, Mol. Cell, 12, 1275, 10.1016/S1097-2765(03)00406-4

McDonald, 2000, β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3, Science, 290, 1574, 10.1126/science.290.5496.1574

Karandikar, 2000, MEKK1 binds raf-1 and the ERK2 cascade components, J. Biol. Chem., 275, 40120, 10.1074/jbc.M005926200

Sheikh, 2008, An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice, J. Clin. Invest., 118, 3870, 10.1172/JCI34472

Roy, 2002, KSR is a scaffold required for activation of the ERK/MAPK module, Genes Dev., 16, 427, 10.1101/gad.962902

Ritt, 2006, KSR regulation of the Raf-MEK-ERK cascade, Methods Enzymol., 407, 224, 10.1016/S0076-6879(05)07019-9

Nguyen, 2002, Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo, Mol. Cell. Biol., 22, 3035, 10.1128/MCB.22.9.3035-3045.2002

Brennan, 2011, A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK, Nature, 472, 366, 10.1038/nature09860

Baljuls, 2016, Stabilization of C-RAF:KSR1 complex by DiRas3 reduces availability of C-RAF for dimerization with B-RAF, Cell Signal., 28, 1451, 10.1016/j.cellsig.2016.06.019

Li, 1998, Dual function of Ras in Raf activation, Development, 125, 4999, 10.1242/dev.125.24.4999

Anderson, 2006, Role of lipids in the MAPK signaling pathway, Prog. Lipid Res., 45, 102, 10.1016/j.plipres.2005.12.003

Yoon, 2006, The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions, Growth Factors, 24, 21, 10.1080/02699050500284218

Cseh, 2014, ‘RAF’ neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway, FEBS Lett., 588, 2398, 10.1016/j.febslet.2014.06.025

Blaževitš, 2016, Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering, Sci. Rep., 6, 24165, 10.1038/srep24165

Chen, 2001, Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism, Proc. Natl Acad. Sci. U.S.A., 98, 7783, 10.1073/pnas.141224398

Romano, 2014, Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling, Nat. Cell Biol., 16, 673, 10.1038/ncb2986

Varga, 2017, RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKalpha, Sci. Signal., 10, eaai8482, 10.1126/scisignal.aai8482